In my trepidation today I decided to reexamine why I invested in RVX. 

My initial purchase of 8700 shares was made in May 2013 - I was convalescing after open heart surgery and researching for therapies to heal or restore my damaged heart muscle. Shortly after I bought RVX, and much to my dismay, the Assure results were announced. I hung onto the my position after I read the post trial analysis and Hepa saved the day and rewarded me with some Zenith shares. Since then I have followed this stock on a daily basis, reading all news releases, all posts on Agora, Stockhouse, IV, all financial reports and MD&As, and all other published data. I have added considerably to my position as I was inclined and have realized some profits as the markets allowed. I also took some hits along the way.  On the eve of BetOnMace top line read out, I am confident that RVX-208 will achieve better than satisfactory (blockbuster) results.

A read of Management's Discussion & Analysis - Q1, 2020, published July 31, 2019 pages 3-12 reaffirmed my confidence in my investment in this novel new therapy - apabetalone, and managements' ability to design a suitable trial and deliver the results. The darkest hour is just before dawn. We have a Winner! JMO

GLTA

Chicagoest